On June 10, the FDA’s Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee voted 11-0, unanimously recommending approval of the Elie LillyLLY’s Alzheimer’s drug, donanemab....
Eli Lilly headquarters in Indianapolis, Indiana, U.S., on Wednesday, May 3, 2023. Shares of Eli Lilly & Co. rose in early U.S. trading after its experimental...
